性欧美视频69_在线播放观看av_Av在线无码网址_在线五月丁香婷啪AV

歡迎光臨! 當(dāng)前位置： 首頁 > 詳細(xì)內(nèi)容

<%=currentDocument.Title%> PDF

       噁唑啉是含有N和O原子的五元雜環(huán)化合物，其中N原子可作為供電子原子能與Cu、Mg、Ni、Pd、Zn、Rh等多種金屬離子配位。近年來，手性噁唑啉配體的合成及其應(yīng)用研究是有機(jī)合成化學(xué)領(lǐng)域比較活躍的課題之一。

       手性噁唑啉配體具有結(jié)構(gòu)的多樣性、手性源易得、不對稱誘導(dǎo)性能好等優(yōu)點(diǎn)在不對稱合成中有著廣泛應(yīng)用，例如Diels-Alder反應(yīng)，Mannich反應(yīng)，Heck反應(yīng)，Henry反應(yīng)，酮的硅氫化反應(yīng)，端基炔烴的加成，醛的烯丙基化反應(yīng)，鈀催化的烯丙基化反應(yīng)等。

       百靈威可以提供TOX & SaBOX、PyBox, Box, Phox等配體種類，品質(zhì)優(yōu)異，涵蓋了噁唑啉配體應(yīng)用的所有類別，充分滿足您的實(shí)驗(yàn)需求。

■ TOX & SaBOX

環(huán)丙烷的[3+3]不對稱環(huán)化反應(yīng) & 不對稱開環(huán)反應(yīng)
Tang, Y. et al., Angew. Chem.Int. Ed. 2013, 52, 1452
Tang, Y. et al., J. Am. Chem.Soc. 2012, 134, 9066
 
配體1579639的更多應(yīng)用，請見下列文獻(xiàn)
a) Tang, Y. et al., Angew. Chem. Int. Ed. 2010. 49, 4463
b) Tang, Y. et al., Tetrahedron2012, 68, 5042
c) Jason S, et al., Org. Lett.2011, 13, 2004
d) Jason S, et al., Synthesis, 2012, 44, 686
Tang, Y. et al., J. Am. Chem. Soc. 2013, 135, 7851.
 
烯烴的不對稱環(huán)丙烷化反應(yīng)

Tang, Y. et al., Angew. Chem. Int. Ed. 2012, 51, 8838
Tang, Y. et al., Angew. Chem. Int. Ed. 2012, 51, 11620
產(chǎn)品編號
產(chǎn)品名稱
CAS
(3aS,3a'S,3a''S,8aR,8a'R,8a''R)-2,2',2''-(Propane-1,2,2-triyl)tris(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 99%
(3aS,3a'S,3a''S,8aR,8a'R,8a''R)-2,2',2''-(丙烷-1,2,2-三基)三(8,8a-二氫-3aH-茚并[1,2-d]噁唑)
(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 99%
(4S,4'S)-2,2'-(1-苯丙烷-2,2-二基)雙(4-苯基-4,5-二氫噁唑)
(4S,4'S)-2,2'-(1,3-Bis(4-(tert-butyl)phenyl)propane-2,2-diyl)bis(4-phenyl-4,5-dihydrooxazole), 99%
(4S,4'S)-2,2'-(1,3-雙(4-(叔丁基)苯基)丙烷-2,2-二基)雙(4-苯基-4,5-二氫噁唑)
(3aS,3a'S,8aR,8a'R)-2,2'-(1,3-bis(3,5-di-tert-butylphenyl)propane-2,2-diyl)bis(8,8a-dihydro-3aH-indeno[1,2-d]oxazole), 99%
(3aS,3a'S,8aR,8a'R)-2,2'-(1,3-雙(3,5-二叔丁基苯基)雙(8,8a-二氫-3aH-茚并[1,2-d]噁唑)

 ■ PyBOX 

吡咯對靛紅的加成反應(yīng)
Org. Lett., 2011,13 (21), 5754-5757
 
疊氮-炔烴環(huán)加成反應(yīng)
J.Am.Chem.Soc., 2013, 135 (30), 10994-10997

產(chǎn)品編號
產(chǎn)品名稱
CAS
2,6-Bis[(4S)-(-)-isopropyl-2-oxazolin-2-yl]pyridine, 99%
2,6-雙[(4S)-(-)-異丙基-2-噁唑啉-2-基]吡啶
2,6-Bis[(4R)-(+)-isopropyl-2-oxazolin-2-yl]pyridine, 98%
2,6-雙[(4R)-(+)-異丙基-2-噁唑啉-2-基]吡啶
2,6-Bis[(4R)-4-phenyl-2-oxazolinyl]pyridine, 98%
2,6-雙[(4R)-4-苯基-2-噁唑啉基]吡啶
2,6-Bis[(4S)-4-phenyl-2-oxazolinyl]pyridine, 98%
2,6-雙[(4S)-4-苯基-2-噁唑啉基]吡啶
2,6-Bis[(3aR,8aS)-(+)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine, 95%
2,6-雙[(3aR,8aS)-(+)-8H-茚并[1,2-d]噁唑啉-2-基]吡啶
2,6-Bis[(3aS,8aR)-(-)-8H-indeno[1,2-d]oxazolin-2-yl)pyridine, 95%
2,6-雙[(3aS,8aR)-(-)-8H-茚并[1,2-d]噁唑啉-2-基]吡啶
2,6-Bis[(4S)-4,5-dihydro-4-(1-methylethyl)-5,5-diphenyl-2-oxazolyl]-pyridine, 98%
2,6-雙[(4S)-4,5-二氫-4-(1-異丙基)-5,5-二苯基-2-噁唑基]吡啶
2,6-Bis[(4R)-4,5-dihydro-4-(1-methylethyl)-5,5-diphenyl-2-oxazolyl]-pyridine, 98%
2,6-雙[(4R)-4,5-二氫-4-(1-異丙基)-5,5-二苯基-2-噁唑基]吡啶

■ BOX

羰基的α-芳基化反應(yīng)

 

J.Am.Chem.Soc., 2011, 133 (35), 13782-13785
產(chǎn)品編號
產(chǎn)品名稱
CAS
2,2′-Isopropylidenebis[(4S)-4-tert-butyl-2-oxazoline], 98%
2,2'-異亞丙基雙[(4S)-4-叔丁基-2-噁唑啉]
(+)-2,2′-Isopropylidenebis[(4R)-4-benzyl-2-oxazoline], 98%
(+)-2,2'-異亞丙基雙[(4R)-4-芐基-2-噁唑啉]
(-)-2,2′-Isopropylidenebis[(4S)-4-phenyl-2-oxazoline], 97%
(-)-2,2'-異亞丙基雙[(4S)-4-苯基-2-噁唑啉]
(+)-2,2′-Isopropylidenebis[(4R)-4-phenyl-2-oxazoline], 97%
(+)-2,2'-異亞丙基雙[(4R)-4-苯基-2噁唑啉]
[3aR-[2(3′aR*,8′aS*),3′aβ,8′aβ]]-(+)-2,2′-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 98%
[3aR-[2(3'aR*,8'aS*),3'aβ,8'aβ]]-(+)-2,2'--亞甲基雙[3a,8a-二氫-8H-茚并[1,2-d]噁唑]
[3aS-[2(3′aR*,8′aS*),3′aα,8′aα]]-(-)-2,2′-Methylenebis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole], 98%
[3aS-[2(3'aR*,8'aS*),3'aα,8'aα]]-(-)-2,2'-亞甲基雙[3a,8a-二氫-8H-茚并[1,2-d]噁唑]
(4S,4′S)-2,2′-(Cyclopentane-1,1-diyl)-bis(4-isopropyl-4,5-dihydrooxazole), 95%
(4S,4'S)-2,2'-(環(huán)戊烷-1,1-二基)-雙(4-異丙基-4,5-二氫噁唑)

 ■ PhOX

α-取代的苯乙烯基衍生物的硼氫化反應(yīng)
 
Chem. Commun., 2011, 47, 298-300
產(chǎn)品編號
產(chǎn)品名稱
CAS
(S)-4-tert-Butyl-2-[2-(diphenylphosphino)phenyl]-2-oxazoline, 97%
(S)-4-叔丁基-2-[2-(二苯基膦基)苯基]-2-噁唑啉
(R)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-isopropyl-2-oxazoline, 98%
(R)-(+)-2-[2-(二苯基膦)苯基]-4-異丙基-2-噁唑啉
(S)-(-)-2-[2-(Diphenylphosphino)phenyl]-4-isopropyl-2-oxazoline, 97%
(S)-(-)-2-[2-二苯基膦]苯基]-4-異丙基-2-噁唑啉
(R)-(-)--2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-oxazoline, 97%
(R)-(-)-2-[2-(二苯基膦)苯基]-4-苯基-2-噁唑啉
(S)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-phenyl-2-oxazoline, 97%
(S)-(+)-2-[2-(二苯基膦)苯基]-4-苯基-2-噁唑啉
第1頁 總共1頁